Argenx
ARGX
#506
Rank
โ‚น4.219 T
Marketcap
โ‚น67,986
Share price
3.19%
Change (1 day)
34.40%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2025 (TTM): โ‚น776.72

According to Argenx 's latest financial reports the company's current EPS (TTM) is โ‚น829.78. In 2024 the company made an earnings per share (EPS) of โ‚น1,302 an increase over its 2023 EPS that were of -โ‚น482.71.

EPS history for Argenx from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น776.72-40.35%
2024โ‚น1,302-369.77%
2023-โ‚น482.71-60.46%
2022-โ‚น1,22163.33%
2021-โ‚น747.46-40.37%
2020-โ‚น1,254183.47%
2019-โ‚น442.22123.09%
2018-โ‚น198.2354.93%
2017-โ‚น127.9414.07%
2016-โ‚น112.1613.05%
2015-โ‚น99.21-36.34%
2014-โ‚น155.85209.04%
2013-โ‚น50.43-33.99%
2012-โ‚น76.40185.59%
2011-โ‚น26.75